Q5107
HCPCSInj mvasi 10 mg
Official HCPCS Level II long descriptor
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg
HCPCS Level II code Q5107 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj mvasi 10 mg
Added to HCPCS: 2019-01-01
Nearby codes in Q5
- Q5098Inj ustekinumab-srlf, 1 mg
- Q5099Inj ustekinumab-stba, 1 mg
- Q5100Inj ustekinumab-kfce, 1 mg
- Q5101Injection, zarxio
- Q5103Injection, inflectra
- Q5104Injection, renflexis
- Q5105Inj retacrit esrd on dialysi
- Q5106Inj retacrit non-esrd use
- Q5108Injection, fulphila
- Q5110Nivestym
- Q5111Injection, udenyca 0.5 mg
- Q5112Inj ontruzant 10 mg
- Q5113Inj herzuma 10 mg
- Q5114Inj ogivri 10 mg
- Q5115Inj truxima 10 mg
- Q5116Inj., trazimera, 10 mg
Where this code sits
Krasyn Codes for Chrome
Review coding suggestions beside a validated web workflow. Private pilot.
Request pilot accessSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.